Changes in pupil size or movement might signal mental health issues such as anxiety, neurological disorders, or drug use.

On track for regulatory submission seeking marketing approval of the Optejet UFD in Q4 2025NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ...

Conditions that can cause miosis include: Drugs that can cause constricted pupils include: While miosis means you have extremely small pupils, mydriasis is the opposite. With mydriasis ...

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi® for mydriasis. For more ...

Additionally, revenue during 2023 was derived in part from a milestone payment of $10.0 million attributed to the FDA’s approval of Phentolamine Ophthalmic Solution 0.75%, under brand name RYZUMVI for ...

The combination of cyclopentolate hydrochloride 0.2% and phenylephrine hydrochloride 1% (Cyclomydril ®) is desirable for mydriasis prior to examining premature infants because it delivers lower ...

The company's current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi® for mydriasis. For more information ...